The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paperMassimo Cristofanilli, Klaus Pantel, Jean‐Yves Pierga et al.|Critical Reviews in Oncology/Hematology|2018Cited by 268
From the European Medicines Agency to Project Orbis: new activities and challenges to facilitate UK oncology drug approval following BrexitMark P. Lythgoe, Richard Sullivan, Ajay Aggarwal et al.|The Lancet Oncology|2023Cited by 20
1238eTiP Phase I/IIa, open-label, dose finding, safety and exploratory trial of THEO-260: A novel oncolytic immunotherapy, by intravenous delivery in patients with high grade serous or endometrioid ovarian cancerMariangela Saggese, Jonathan Krell, P. Roxburgh et al.|Annals of Oncology|2025Cited by 1